Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT.

Blood
Roberto NegroD G Efremov

Abstract

A polymorphic variant of the phosphatase PTPN22 has been associated with increased risk for multiple autoimmune diseases. The risk allele is thought to function by diminishing antigen-receptor signals responsible for negative selection of autoreactive lymphocytes. We now show that PTPN22 is markedly overexpressed in chronic lymphocytic leukemia (CLL), a common malignancy of autoreactive B lymphocytes. We also show that overexpression of PTPN22 significantly inhibits antigen-induced apoptosis of primary CLL cells by blocking B-cell receptor (BCR) signaling pathways that negatively regulate lymphocyte survival. More importantly, we show that PTPN22 positively regulates the antiapoptotic AKT kinase, which provides a powerful survival signal to antigen-stimulated CLL cells. This selective uncoupling of AKT from other downstream BCR signaling pathways is a result of inhibition of a negative regulatory circuit involving LYN, CD22, and SHIP. Finally, we show that PTPN22 can be effectively down-regulated by the PKC inhibitors ruboxistaurin and sotrastaurin, resulting in enhanced killing of CLL cells exposed to proapoptotic BCR stimuli. Collectively, these data suggest that PTPN22 overexpression represents a protective mechanism that al...Continue Reading

References

Jan 1, 1989·The Journal of Experimental Medicine·Z M SthoegerN Chiorazzi
Dec 1, 1996·Leukemia & Lymphoma·A C LankesterR A van Lier
Jul 21, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·S L PogueR Herbst
Dec 4, 2002·Nature Reviews. Immunology·Hiroaki Niiro, Edward A Clark
Feb 14, 2004·Blood·Freda K Stevenson, Federico Caligaris-Cappio
Jul 27, 2004·American Journal of Human Genetics·Chieko KyogokuTimothy W Behrens
Aug 18, 2004·The Journal of Experimental Medicine·Bradley T MessmerNicholas Chiorazzi
Jan 25, 2005·Immunity·Yuekang XuDavid M Tarlinton
Feb 25, 2005·The New England Journal of Medicine·Nicholas ChiorazziManlio Ferrarini
Nov 8, 2005·Nature Genetics·Torkel VangNunzio Bottini
Jan 6, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Manabu FujimotoShinichi Sato
Feb 8, 2006·The Journal of Biological Chemistry·Jiansheng WuJames M Clark
Sep 20, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mary RieckJane H Buckner
Nov 3, 2007·Biochemical and Biophysical Research Communications·Bin-Cheng YanTakeshi Tsubata
Nov 24, 2007·Autoimmunity Reviews·Dimitar G EfremovPablo G Longo
Dec 7, 2007·Proceedings of the National Academy of Sciences of the United States of America·Xiao YuZhong-Yin Zhang
Feb 29, 2008·Annual Review of Immunology·Torkel VangTomas Mustelin
Mar 21, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Julie ZikhermanArthur Weiss
May 14, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S FrimanE S Woodle
Aug 2, 2011·The Journal of Clinical Investigation·Laurence MenardEric Meffre

❮ Previous
Next ❯

Citations

Jul 19, 2012·Cell Communication and Signaling : CCS·Evan Ingley
Jan 1, 2012·The Review of Diabetic Studies : RDS·Karen Cerosaletti, Jane H Buckner
Nov 22, 2012·Mediterranean Journal of Hematology and Infectious Diseases·Dimitar G EfremovLuca Laurenti
Dec 25, 2013·Annual Review of Immunology·Nunzio Bottini, Erik J Peterson
Jul 9, 2014·Nature Reviews. Rheumatology·Stephanie M Stanford, Nunzio Bottini
Dec 20, 2015·Immunological Reviews·Jessica A HamermanJane H Buckner
Jul 23, 2014·Pharmacology & Therapeutics·Elisa ten Hacken, Jan A Burger
Nov 18, 2014·Biochemical Society Transactions·Anuradha Tarafdar, Alison M Michie
Aug 1, 2015·Blood Cells, Molecules & Diseases·Kamil BojarczukMagdalena Winiarska
Oct 5, 2013·Blood·Daniel H Fowler
Jul 28, 2016·Journal of Dermatological Science·Mohmmad Shoab MansuriRasheedunnisa Begum
Jun 20, 2017·Nature Genetics·Stefan JonssonKari Stefansson
Jan 7, 2018·Clinical Science·Shu-Han YangZhe-Xiong Lian
Jan 23, 2015·Molecular Medicine·Nino PorakishviliPeter M Lydyard
Jan 6, 2018·Nature Reviews. Cancer·Markus Müschen
Aug 6, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hui-Hsin ChangI-Cheng Ho
Mar 22, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·David J RawlingsJane H Buckner
Apr 26, 2017·Frontiers in Immunology·Prontip SaeleeLee Ann Garrett-Sinha
Feb 2, 2018·European Journal of Immunology·Karine CheminVivianne Malmström
May 1, 2016·International Journal of Hematologic Oncology·John C AllenJoseph R Slupsky
Jan 5, 2013·Blood·Scott J HebbringSteven J Schrodi
May 5, 2018·Cellular and Molecular Life Sciences : CMLS·Goutham NarlaChristopher B Ryder
Dec 15, 2019·The Journal of Immunology : Official Journal of the American Association of Immunologists·Simar Pal SinghRudi W Hendriks
May 10, 2020·HemaSphere·Nicholas Chiorazzi, Freda K Stevenson
Mar 19, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shuangping GuoWing C Chan
Dec 11, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elisa ten Hacken, Jan A Burger
Jan 12, 2021·Frontiers in Cell and Developmental Biology·Patricia Castro-SanchezRose Zamoyska
Mar 16, 2021·Frontiers in Immunology·Lucas H ArmitageClayton E Mathews

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Mediterranean Journal of Hematology and Infectious Diseases
D G EfremovL Laurenti
The Journal of Immunology : Official Journal of the American Association of Immunologists
Adrian F ArechigaJane H Buckner
The Journal of Immunology : Official Journal of the American Association of Immunologists
Christian J MaineLinda A Sherman
© 2021 Meta ULC. All rights reserved